Literature DB >> 21537864

Normal PTH levels in primary hyperparathyroidism: still the same disease?

Amanda L Amin1, Tracy S Wang, Thomas J Wade, Tina W F Yen.   

Abstract

PURPOSE: Previous studies have suggested that primary hyperparathyroidism (pHPT) with only normal parathyroid hormone (PTH) levels is a milder, less symptomatic form of pHPT. This study investigates symptoms, laboratory values, imaging, and outcomes of sporadic pHPT patients with normal PTH values.
METHODS: We reviewed our prospectively collected database of 861 patients with sporadic pHPT who underwent parathyroidectomy between December 1999 and June 2010. Patients with only normal PTH values for 6 months before surgery were compared to a randomized control group of sporadic pHPT patients with elevated PTH, matched 1:2 for age and gender.
RESULTS: Fifty-eight (7%) patients had only normal PTH values within 6 months of surgery. The mean PTH was 55.1 pg/ml in the normal PTH group and 151.3 pg/ml in the control group (n=116). There was no difference in preoperative calcium values, subjective symptoms, bone health, or the frequency of single-gland disease (SGD; 88% vs. 91%) between the two groups, but the normal PTH group had higher preoperative vitamin D values (30.8 vs. 21.4 ng/ml; P<0.001), smaller adenomas (405 vs. 978 mg, P<0.001), and more frequently underwent bilateral neck exploration (57% vs. 49%). There was a trend toward lower sensitivity of preoperative imaging in the normal PTH group.
CONCLUSIONS: Patients with pHPT and either elevated or normal PTH levels present with similar symptoms and calcium levels. The majority of patients with normal PTH have SGD, although adenomas are smaller. This may explain why patients with normal PTH values have less sensitive imaging and more frequently require four-gland exploration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537864     DOI: 10.1245/s10434-011-1744-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

2.  Surgery for Primary Hyperparathyroidism with Normal Non-suppressed Parathyroid Hormone can be Both Challenging and Successful.

Authors:  Lauren E Orr; Travis J McKenzie; Geoffrey B Thompson; David R Farley; Robert A Wermers; Melanie L Lyden
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Surgical treatment of patients with mildly elevated parathormone and calcium levels.

Authors:  Punam P Parikh; Bassan J Allan; John I Lew
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  PRIMARY HYPERPARATHYROIDISM DETECTED BY PARATHYROID INCIDENTALOMA: CLINICAL FEATURES, WORK-UP AND MANAGEMENT.

Authors:  V Pandzic Jaksic; A Majic; T Rezic; J Andric; O Jaksic; A Zrilic; S Marusic
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

5.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  Surgical management of MILD hyperparathyroidism.

Authors:  Adèle Lecourt; Gwenaëlle Creff; Paul Coudert; Olivier De Crouy Chanel; Pascal Guggenbuhl; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-30       Impact factor: 2.503

7.  Huge brown tumor of the rib in an unlocatable hyperparathyroidism patient with "self-recovered" serum calcium and parathyroid hormone: A case report.

Authors:  Wen-Da Wang; Ning Zhang; Qiang Qu; Xiao-Dong He
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

8.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

9.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.